N. Morelli (Den Haag, Netherlands), N. Kahn (Heidelberg, Germany)
Late Breaking Abstract - Rituximab limits the progression of fibrosing mediastinitis
C. Varghese (Rochester, United States of America), G. Johnson (Rochester, United States of America), P. Eiken (Rochester, United States of America), P. Tobias (Rochester, United States of America)
|    |
Development of Pulmonary Arteriovenous Malformations and Occurrence of Neurological Complications in patients with Hereditary Haemorrhagic Telangiectasia with isolated micronodules and/or intrapulmonary shunt at first screening
V. Margelidon-Cozzolino (Bron, France), C. Khouatra (Bron, France), J. Traclet (Bron, France), K. Ahmad (Bron, France), S. Dupuis-Girod (Bron, France), V. Cottin (Bron, France)
| |
Risk factors for postoperative acute exacerbation of interstitial lung diseases: a matched case-control study
K. Hosoki (Tokyo, Japan), Y. Mikami (Tokyo, Japan), T. Jo (Tokyo, Japan), K. Soma (Tokyo, Japan), H. Urushiyama (Tokyo, Japan), T. Nagase (Tokyo, Japan)
| |
Clinical features of autoimmune pulmonary alveolar proteinosis from a large international patient cohort: baseline data from the IMPALA trial
B. Trapnell (Cincinnati, United States of America), C. Ganslandt (Austin, United States of America), I. Tarnow (Austin, United States of America), T. Jouhikainen (Austin, United States of America), G. Waterer (Perth, Australia), C. Morgan (London, United Kingdom)
| |
Shrinking lung syndrome (SLS) associated with systemic lupus erythematosus (SLE): A series of cases in a university hospital.
A. Casey (Buenos Aires, Argentina), M. Perin (Buenos Aires, Argentina), J. Enghelmayer (Buenos Aires, Argentina), C. Legarreta (Buenos Aires, Argentina), F. Zenon (Buenos Aires, Argentina), P. Rossi (Buenos Aires, Argentina), S. Acuña (Buenos Aires, Argentina), A. Betancourt (Buenos Aires, Argentina), R. Gomez (Buenos Aires, Argentina), A. Beron (Buenos Aires, Argentina), D. Dubinsky (Buenos Aires, Argentina), A. Putruele (Buenos Aires, Argentina)
| |
Evaluating the effect of long-term idebenone treatment on respiratory morbidity in patients with Duchenne muscular dystrophy (DMD)
O. Mayer (Philadelphia, United States of America), M. Leinonen (Pratteln, Switzerland), L. Servais (Liege, Belgium), C. Straathof (Leiden, Netherlands), U. Schara (Essen, Germany), T. Voit (London, United Kingdom), E. Mercuri (Rome, Italy), G. Buyse On Behalf Of The Syros Investigators (Leuven, Belgium)
|  |
Long term efficacy: Idebenone reduces the rate of both inspiratory and expiratory functional loss in Duchenne muscular dystrophy (DMD)
O. Mayer (Philadelphia, United States of America), M. Leinonen (Pratteln, Switzerland), S. Hasham (Pratteln, Switzerland), G. Buyse On Behalf Of The Syros Investigators (Leuven, Belgium)
| |